These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

237 related items for PubMed ID: 17275471

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Vitamin D receptor BsmI and TagI gene polymorphisms in a Turkish ESRD population: influences on parathyroid hormone response.
    Ozdemir FN, Sezer S, Atac B, Tutal E, Verdi H, Sahin F, Haberal M.
    Transplant Proc; 2005 Sep; 37(7):2922-4. PubMed ID: 16213262
    [Abstract] [Full Text] [Related]

  • 5. BB genotype of the vitamin D receptor gene polymorphism postpones parathyroidectomy in hemodialysis patients.
    Borràs M, Torregrossa V, Oliveras A, Almirall J, Ma Paz M, Betriu A, Martin M, Muray S, Fibla J, Fernández E.
    J Nephrol; 2003 Sep; 16(1):116-20. PubMed ID: 12649542
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Vitamin D receptor gene polymorphisms affect secondary hyperparathyroidism in hemodialyzed patients.
    Nagaba Y, Heishi M, Tazawa H, Tsukamoto Y, Kobayashi Y.
    Am J Kidney Dis; 1998 Sep; 32(3):464-9. PubMed ID: 9740163
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Secondary hyperparathyroidism is associated with vitamin D receptor polymorphism and bone density after renal transplantation.
    Rubello D, Giannini S, D'Angelo A, Nobile M, Carraio G, Rigotti P, Marchini F, Zaninotto M, Dalle Carbonare L, Sartori L, Nibale O, Carpi A.
    Biomed Pharmacother; 2005 Aug; 59(7):402-7. PubMed ID: 16084056
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Effect of intravenous ascorbic acid in hemodialysis patients with EPO-hyporesponsive anemia and hyperferritinemia.
    Attallah N, Osman-Malik Y, Frinak S, Besarab A.
    Am J Kidney Dis; 2006 Apr; 47(4):644-54. PubMed ID: 16564942
    [Abstract] [Full Text] [Related]

  • 13. [Clinical and economic significance of iron replacement in anemia treated with recombinant human erythropoietin in patients on hemodialysis].
    Vanková S, Safárová R, Horácková M, Herink J, Rychlík I, Bahbouh R, Půtová I.
    Cas Lek Cesk; 2001 Apr 12; 140(7):209-13. PubMed ID: 11374225
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Additional effect of hyperparathyroidism on inflammatory status and rHuEPO requirements in hemodialysis patients.
    Tutal E, Sezer S, Afsar B, Arat Z, Ozdemir FN, Haberal M.
    Transplant Proc; 2006 Nov 12; 38(9):2807-12. PubMed ID: 17112835
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Identification of poor responders to erythropoietin among children undergoing hemodialysis.
    Seeherunvong W, Rubio L, Abitbol CL, Montané B, Strauss J, Diaz R, Zilleruelo G.
    J Pediatr; 2001 May 12; 138(5):710-4. PubMed ID: 11343048
    [Abstract] [Full Text] [Related]

  • 19. Vitamin D receptor gene polymorphisms are not associated with alopecia areata.
    Akar A, Orkunoglu FE, Tunca M, Taştan HB, Kurumlu Z.
    Int J Dermatol; 2007 Sep 12; 46(9):927-9. PubMed ID: 17822494
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.